Results

Total Results: 296 records

Showing results for "colorectal outcomes".

101. Current Processes: Refining Evidence-based Recommendation Development - Table 2 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/current-processes-refining-evidence-based-recommendation-development-table-2
     June 01, 2007 - Use of outcomes tables to assess balance of benefits and harms. … Routine aspirin or nonsteroidal antiinflammatory drugs for the primary prevention of colorectal cancer

102. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - Appendix C | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services-appendix-c
     December 01, 2011 - A Colorectal Cancer: Screening in Adults Ages 50 to 75 Years The USPSTF recommends screening … screening for colorectal cancer in adults ages 76 to 85 years. … screening for colorectal cancer in adults older than age 85 years. … cancer in adults at average risk for colorectal cancer. … recommend routine screening for developmental dysplasia of the hip in infants as a means to prevent adverse outcomes

103. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - V | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services-v
     December 01, 2011 - Whereas the ability of primary care-based interventions to lead directly to changes in health outcomes … Screening for Colorectal Cancer With New Modalities Colorectal cancer screening is effective in saving … Recently developed technologies hold promise for extending the reach of colorectal cancer screening programs … (including long-term outcomes) in a standardized fashion are needed. … outcomes are also needed.  

104. Draft Research Plan: Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/folic-acid-supplementation-prevent-neural-tube-defects
     July 22, 2021 - KQs 1a, 1b, 1c (timing, duration), 2a: Lower vs. higher doses of folic acid supplementation Outcomes … Neonatal outcomes: NTDs Harms from treatment: Twins Colorectal cancer or other reported types

105. Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/inevidup.pdf
     September 01, 2009 - For some preventive services, the long timeline required to improve health outcomes makes RCTs impractical … Consensus is lacking about the appro­ priate outcomes for preventive interventions in children, although … Colorectal Cancer Screening The recently published USPSTF recommendation on colorectal cancer screening … This conclusion was based on the lack of evidence on the long-term outcomes of treat­ ment for high … Teutsch: Outcomes Research, Merck & Co., West Point, PA 19486. Dr.

106. Screening for Ovarian Cancer - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/za7BqXMwT8BMz4Z_ygrvKm
     May 01, 2004 - currently in progress: the UK Collaborative Trial of Ovarian Cancer Screening; the NIH Prostate, Lung, Colorectal … The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute … Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. … The USPSTF found at least fair evidence that [the service] can improve health outcomes but concludes … Poor: Evidence is insufficient to assess the effects on health outcomes because of limited number or

107. Screening for Ovarian Cancer: A Brief Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k2QHcwuK4NkvxFXhvGrbwY
     May 01, 2004 - Screening studies with early detection outcomes. … Screening studies with mortality outcomes. … Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial … The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute … Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

108. The U.S. Preventive Services Task Force: An Evidence-Based Prevention Resource for Nurse Practitioners | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/evidence-based-prevention-resource-nurse-practitioners
     April 01, 2019 - developed includes the following steps: Creation of an analytic framework and a set of key questions and outcomes … Screening and counseling to prevent tobacco use and screening for colorectal cancer are two important … The Task Force recommends that clinicians screen men and women 50 years of age or older for colorectal … Yet only about half of adults over the age of 50 receive appropriate colorectal cancer screening with … Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. 

109. Draft Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/statin-use-primary-prevention-cardiovascular-disease-adults
     July 09, 2020 - currently being addressed in a separate USPSTF review on aspirin use for the primary prevention of CVD and colorectal … vs. fixed dose therapy KQ 3: Higher- vs. lower-potency statin therapy Other comparisons Outcomes … loss, diabetes, elevations in liver function tests or creatinine phosphokinase levels Intermediate outcomes

110. Archived: Final Evidence Review: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
     May 15, 2004 - increased risk for breast cancer. 9 Carriers of the BRCA2 gene are at increased risk for ovarian, colorectal … with mortality outcomes have been completed, although some are currently in progress. … Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial … The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute … Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

111. Evidence Summary: Aspirin Use to Prevent Cardiovascular Events: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cardiovascular/aspirin-to-prevent-cardiovascular-disease-and-cancer
     April 11, 2016 - Summary: Aspirin Use to Prevent Cardiovascular Events Aspirin Use to Prevent Cardiovascular Disease and Colorectal … with additional evidence about harms, 18 a decision model, 19 and concurrent reviews on aspirin and colorectal … simulations do not include considerations of harm and the potential long-term benefit from reduced colorectal … Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: A Decision Analysis. … Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the U.S

112. Archived: Final Research Plan: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
     October 22, 2015 - The first (KQ 1) examines the improved health outcomes that may result from hormone therapy when used … Drug Administration) Control interventions Placebo, no treatment Active comparator Outcomes … chronic conditions of interest) Coronary heart disease Stroke Thromboembolism Cancer (breast, colorectal … that are not health outcomes of chronic conditions associated with hormone therapy (e.g., intermediate … outcomes, such as bone density and cholesterol level) Duration of intervention ≥1 year of treatment

113. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rn7dRezgMx5syB-erQKoKt
     November 01, 2022 - plus progestin compared with placebo experienced significantly lower risks, per 10 000 persons, for colorectal … The questions are depicted by linkages that relate interventions and outcomes. … Four trials16,42,50,89,96 with data on more than 20 000 persons reported on the incidence of colorectal … Some of the nonsignificant outcomes, however, Table 1. … Estrogen plus progestin and colorectal cancer in postmenopausal women.

114. Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer
     April 11, 2016 - Evidence Summary: Bleeding Risks With Aspirin Use Aspirin Use to Prevent Cardiovascular Disease and Colorectal … The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the … Circ Cardiovasc Qual Outcomes . 2014;7:70-7. [PMID: 24254886] 42. … Colorectal Dis . 2014;16:O189-96. [PMID: 24320820] 54. … Curr Colorectal Cancer Reports . 2013;9:9-16. Return to Table of Contents Figure 1.

115. Final Research Plan: Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
     October 21, 2021 - KQs 1a, 1b, 1c (timing, duration), 2a: Lower vs. higher doses of folic acid supplementation Outcomes … Neonatal outcomes: NTDs Harms from treatment: Colorectal cancer or other reported types of cancer

116. Archived: Final Evidence Review: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review78/ovarian-cancer-screening-2012
     April 15, 2012 - ovarian cancer, 34 studies that did not describe screening, two studies that described no relevant outcomes … colleagues report the results of the initial ovarian cancer screening round within the Prostate, Lung, Colorectal … include soluble tumor necrosis factor receptors 9 , which are associated with worse ovarian cancer outcomes … Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: … Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

117. Recommendation: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     June 21, 2022 - behavioral counseling to decrease risk of skin cancer, 21 screening for breast, 22 cervical, 23 colorectal … moderately elevated homocysteine levels, 41 and the others were limited to adults with a history of colorectal … Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. … Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. … A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.

118. Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/statin-use-in-adults-preventive-medication
     November 05, 2020 - currently being addressed in a separate USPSTF review on aspirin use for the primary prevention of CVD and colorectal … fixed dose therapy KQ 3: Higher- vs. lower-intensity statin therapy Other comparisons Outcomes … , cataracts, elevations in liver function tests or creatinine phosphokinase levels Intermediate outcomes

119. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
     January 01, 1996 - archived Final Recommendation Statement Aspirin Use to Prevent Cardiovascular Disease and Colorectal … mortality (6% reduction) in the treated group. 6 Although the apparent absence of an effect on these outcomes

120. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Evidence Summary: Bleeding Risks With Aspirin Use Aspirin Use to Prevent Cardiovascular Disease and Colorectal … The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the … Circ Cardiovasc Qual Outcomes . 2014;7:70-7. [PMID: 24254886] 42. … Colorectal Dis . 2014;16:O189-96. [PMID: 24320820] 54. … Curr Colorectal Cancer Reports . 2013;9:9-16. Return to Table of Contents Figure 1.